OrthoPediatrics Corp. (KIDS) News
Filter KIDS News Items
KIDS News Results
|Loading, please wait...|
KIDS News Highlights
- For KIDS, its 30 day story count is now at 3.
- Over the past 22 days, the trend for KIDS's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- BEAT are the most mentioned tickers in articles about KIDS.
Latest KIDS News From Around the Web
Below are the latest news stories about Orthopediatrics Corp that investors may wish to consider to help them evaluate KIDS as an investment opportunity.
OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Company’s partnership with Mighty Oak Medical for 3D printed, patient-specific technology continues advancing pediatric scoliosis treatmentWARSAW, Ind., Feb. 23, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the 1,000th case performed with the FIREFLY® Pedicle Screw Navigation Guides (“FIREFLY”) technology in collaboration with Mighty Oak Medical. FIREFLY
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
WARSAW, Ind., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2021 financial results on Wednesday, March 2, 2022, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 3, 2022, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-46
E ratio of….
WARSAW, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2021. Preliminary unaudited fourth quarter 2021 revenue is expected to be $24.8 million, up 31%, when compared to $18.9 million in the fourth quarter of 2020. Preliminary domestic revenue grew 11%
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on OrthoPediatrics (KIDS – Research Report), with a price target of $68.00. The company's shares closed last Tuesday at $57.78. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 18.4% and a 50.1% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Organogenesis Holdings, and Zimmer Biomet Holdings. Currently, the analyst consensus on OrthoPediatrics is a Strong Buy with an average price target of $75.75, which is a 33.8% upside from current levels.
Have a friend or family member on your holiday shopping list who's interested in the stock market? Let's look at three healthcare stocks you can buy this holiday season, hold forever, and feel good about it. Over 55,000 surgeons worldwide have trained on Intuitive Surgical's (NASDAQ: ISRG) minimally-invasive, da Vinci robotic system, which is utilized for a variety of surgical procedures.
OrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)
WARSAW, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support as a Double-Diamond sponsor of the International Pediatric Orthopaedic Symposium (IPOS), which took place December 7 – 11 in Orlando, Florida. Over 400 pediatric orthopedic surgeons attended the meeting. IPOS, a branch of the Pediatric Orthopedic Society of North America (POSNA), is a leading education
WARSAW, Ind., Nov. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp . (OrthoPediatrics or the Company) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the release of a fireside chat webcast in connection with the 33 rd Annual Piper Sandler Virtual Healthcare Conference. The fireside chat includes participation by Dave Bailey, President & Chief Executive Officer, Fred Hite, Chief Operating Officer and Chief Financial Officer. OrthoPediatrics will be participating in 1x1 investor meetings on December 1, 2021. Meetings can be requested exclusively via Piper Sandler
Third Quarter 2021 Revenue Increased 13% Year-over-YearWARSAW, Ind., Nov. 03, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the third quarter ended September 30, 2021. Third Quarter 2021 and Business Highlights Generated total revenue of $25.1 million for third quarter 2021, up 13% from $22.2 million in third quarter 2020;